+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Peptide Therapeutics Market Analysis 2017 - Forecast to 2025

  • ID: 4609408
  • Report
  • Region: Global
  • 184 pages
  • Hoovers Research
1 of 3

FEATURED COMPANIES

  • Amgen, Inc.
  • Bachem Holding AG
  • Bristol-Myers Squibb(BMS)
  • GlaxoSmithKline
  • Lonza Inc.
  • Novo Nordisk A/S
  • MORE
The publisher's analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
  • Market Sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities,)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen, Inc.
  • Bachem Holding AG
  • Bristol-Myers Squibb(BMS)
  • GlaxoSmithKline
  • Lonza Inc.
  • Novo Nordisk A/S
  • MORE
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Peptide Therapeutics Market by Type of Molecule
5.1 Introduction
5.2 Natriuretic
5.3 Vasopressin
5.4 Calcitonin
5.5 Somatostatin
5.6 Immunopeptide
5.7 Other Type of Molecules

6 Peptide Therapeutics Market by Route of Administration
6.1 Introduction
6.2 Oral
6.3 Mucosal
6.4 Parenteral
6.5 Pulmonary
6.6 Other Route of Administrations

7 Peptide Therapeutics Market by Application
7.1 Introduction
7.2 Cardiovascular Disease
7.3 Dermatology
7.4 The Gastrointestinal (GIT)
7.5 Renal
7.6 Central Nervous System (CNS)
7.7 Cancer
7.8 Cardiovascular Disorder
7.9 Anti-infective
7.10 Metabolic
7.11 Pain
7.12 Respiratory
7.13 Other Applications

8 Peptide Therapeutics Market by Technology
8.1 Introduction
8.2 Hybrid Phase
8.3 Liquid Phase
8.4 Solid Phase

9 Peptide Therapeutics Market by Type of Manufacturers
9.1 Introduction
9.2 Outsourced
9.3 In-house

10 Peptide Therapeutics Market by Type
10.1 Introduction
10.2 Innovative
10.3 Generic

11 Geographical Segmentation
11.1 North America
11.1.1 US
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 UK
11.2.5 Spain
11.3 Asia Pacific
11.3.1 Japan
11.3.2 China
11.3.3 India
11.3.4 Australia
11.3.5 New Zealand
11.3.6 Rest of Asia Pacific
11.4 South America
11.4.1 Argentina
11.4.2 Brazil
11.4.3 Venezuela
11.4.4 Chile
11.4.5 Peru
11.5 Middle East & Africa
11.5.1 UAE
11.5.2 Saudi Arabia
11.5.3 Qatar
11.5.4 Iran
11.5.5 South Africa
11.5.6 Rest of MEA

12 Vendor Landscaping
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiles
13.1 Bachem Holding AG
13.2 Sanofi
13.3 Hoffmann-La Roche Ltd.
13.4 Novartis AG
13.5 GlaxoSmithKline
13.6 Pfizer, Inc.
13.7 Teva Pharmaceutical Industries Ltd.
13.8 Bachem Holding AG
13.9 Takeda Pharmaceutical Company Limited
13.10 Amgen, Inc.
13.11 Eli Lilly and Company
13.12 Lonza Inc.
13.13 Bristol-Myers Squibb(BMS)
13.14 AstraZeneca PLC
13.15 Novo Nordisk A/S
14 Appendix
15 Disclaimer

List of Tables
Table 1 Global Peptide Therapeutics Market Analysis, by Region, (2016-2025) ($MN)
Table 2 Global Peptide Therapeutics Market Analysis, by Type of Molecule, (2016-2025) ($MN)
Table 3 Global Peptide Therapeutics Market Analysis, by Natriuretic, (2016-2025) ($MN)
Table 4 Global Peptide Therapeutics Market Analysis, by Vasopressin, (2016-2025) ($MN)
Table 5 Global Peptide Therapeutics Market Analysis, by Calcitonin, (2016-2025) ($MN)
Table 6 Global Peptide Therapeutics Market Analysis, by Somatostatin, (2016-2025) ($MN)
Table 7 Global Peptide Therapeutics Market Analysis, by Immunopeptide, (2016-2025) ($MN)
Table 8 Global Peptide Therapeutics Market Analysis, by Other Type of Molecules, (2016-2025) ($MN)
Table 9 Global Peptide Therapeutics Market Analysis, by Route of Administration, (2016-2025) ($MN)
Table 10 Global Peptide Therapeutics Market Analysis, by Oral, (2016-2025) ($MN)
Table 11 Global Peptide Therapeutics Market Analysis, by Mucosal, (2016-2025) ($MN)
Table 12 Global Peptide Therapeutics Market Analysis, by Parenteral, (2016-2025) ($MN)
Table 13 Global Peptide Therapeutics Market Analysis, by Pulmonary, (2016-2025) ($MN)
Table 14 Global Peptide Therapeutics Market Analysis, by Other Route of Administrations, (2016-2025) ($MN)
Table 15 Global Peptide Therapeutics Market Analysis, by Application, (2016-2025) ($MN)
Table 16 Global Peptide Therapeutics Market Analysis, by Cardiovascular Disease, (2016-2025) ($MN)
Table 17 Global Peptide Therapeutics Market Analysis, by Dermatology, (2016-2025) ($MN)
Table 18 Global Peptide Therapeutics Market Analysis, by The Gastrointestinal (GIT), (2016-2025) ($MN)
Table 19 Global Peptide Therapeutics Market Analysis, by Renal, (2016-2025) ($MN)
Table 20 Global Peptide Therapeutics Market Analysis, by Central Nervous System (CNS), (2016-2025) ($MN)
Table 21 Global Peptide Therapeutics Market Analysis, by Cancer, (2016-2025) ($MN)
Table 22 Global Peptide Therapeutics Market Analysis, by Cardiovascular Disorder, (2016-2025) ($MN)
Table 23 Global Peptide Therapeutics Market Analysis, by Anti-infective, (2016-2025) ($MN)
Table 24 Global Peptide Therapeutics Market Analysis, by Metabolic, (2016-2025) ($MN)
Table 25 Global Peptide Therapeutics Market Analysis, by Pain, (2016-2025) ($MN)
Table 26 Global Peptide Therapeutics Market Analysis, by Respiratory, (2016-2025) ($MN)
Table 27 Global Peptide Therapeutics Market Analysis, by Other Applications, (2016-2025) ($MN)
Table 28 Global Peptide Therapeutics Market Analysis, by Technology, (2016-2025) ($MN)
Table 29 Global Peptide Therapeutics Market Analysis, by Hybrid Phase, (2016-2025) ($MN)
Table 30 Global Peptide Therapeutics Market Analysis, by Liquid Phase, (2016-2025) ($MN)
Table 31 Global Peptide Therapeutics Market Analysis, by Solid Phase , (2016-2025) ($MN)
Table 32 Global Peptide Therapeutics Market Analysis, by Type of Manufacturers, (2016-2025) ($MN)
Table 33 Global Peptide Therapeutics Market Analysis, by Outsourced, (2016-2025) ($MN)
Table 34 Global Peptide Therapeutics Market Analysis, by In-house, (2016-2025) ($MN)
Table 35 Global Peptide Therapeutics Market Analysis, by Type, (2016-2025) ($MN)
Table 36 Global Peptide Therapeutics Market Analysis, by Innovative, (2016-2025) ($MN)
Table 37 Global Peptide Therapeutics Market Analysis, by Generic, (2016-2025) ($MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bachem Holding AG
  • Sanofi
  • Hoffmann-La Roche Ltd.
  • Novartis AG
  • GlaxoSmithKline
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bachem Holding AG
  • Takeda Pharmaceutical Company Limited
  • Amgen, Inc.
  • Eli Lilly and Company
  • Lonza Inc.
  • Bristol-Myers Squibb(BMS)
  • AstraZeneca PLC
  • Novo Nordisk A/S
Note: Product cover images may vary from those shown
Adroll
adroll